MICI Q3 2026
July 7, 2026
Share this article:
2026 MICI Q3 Shows Overall Confidence Remains High
The Medical Imaging Confidence Index (MICI) Q4 2025 results show overall trends continuing. Confidence remains very high regarding monthly growth in study volume and the ability of departments to maintain/grow as a profit center. Hospitals with 100+ beds saw a significant increase in confidence regarding access to capital for imaging equipment and IT needs as compared to Q4 2025.
Co-developed with AHRA, MICI benchmarks the business climate in imaging with quarterly findings about current and future trends for medical imaging reimbursement, revenue, cost, purchasing, and growth. If you’re ready to use detailed MICI report findings to improve your imaging forecasting process, please contact us to learn more.
Q2 2026 IVD market analysis across Core Lab, Molecular Dx, and Microbiology/Specialty Dx, with a 12-company competitive scorecard, management VOC quotes, and a Q3 2026 outlook from Ensolve Research.
New imagePRO QuickPoll findings reveal how recent Medicare ASC reimbursement changes are affecting imaging procedure volumes, health systems, and key modalities.
Learn how to conduct a healthcare market study, from defining research objectives and audiences to selecting methodologies and turning insights into strategy.